Rifamycin S

Rifamycin S (CAS No.: 13553-79-2) is a rifamycin class quinone natural product derivative of microbial origin that is broadly used as a biochemical tool in antibacterial and transcription focused research, primarily categorized within anti infective mechanism studies and RNA synthesis modulation in bacterial systems, where it is recognized to inhibit bacterial DNA dependent RNA polymerase and thereby suppress transcriptional processes in susceptible Gram positive organisms including methicillin resistant Staphylococcus aureus models, while its redox active quinone framework is also associated with a reversible two electron oxidation reduction behavior that can influence reactive oxygen species related cellular stress readouts and modulation of microsomal lipid peroxidation in experimental settings; reported activity patterns for rifamycin family members are generally observed from nanomolar to micromolar ranges depending on strain background, assay format, and resistance profile, and in vitro use commonly includes bacterial growth inhibition assays, enzyme level transcription inhibition assays, resistance mechanism interrogation, and combination screening paradigms, with additional exploratory use in cell based oxidative stress or membrane damage related mechanistic studies, whereas in vivo preclinical investigations may employ infection relevant animal models to examine pharmacology and exposure response relationships under strictly controlled research conditions, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.